Bausch Health Companies Stock Analysis

BHC Stock  USD 9.18  0.19  2.11%   
Bausch Health Companies is fairly valued with Real Value of 9.19 and Target Price of 9.67. The main objective of Bausch Health stock analysis is to determine its intrinsic value, which is an estimate of what Bausch Health Companies is worth, separate from its market price. There are two main types of Bausch Health's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Bausch Health's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Bausch Health's stock to identify patterns and trends that may indicate its future price movements.
The Bausch Health stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Bausch Health is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Bausch Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Bausch Health's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Bausch Stock Analysis Notes

About 80.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.63. Bausch Health Companies recorded a loss per share of 1.62. The entity last dividend was issued on the 10th of November 2010. The firm had 2:1 split on the 16th of October 2000. Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. is headquartered in Laval, Canada. Bausch Health is traded on New York Stock Exchange in the United States. For more info on Bausch Health Companies please contact Joseph Papa at 514 744 6792 or go to https://www.bauschhealth.com.

Bausch Health Quarterly Total Revenue

2.41 Billion

Bausch Health Companies Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Bausch Health's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Bausch Health Companies or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
The company reported the last year's revenue of 8.76 B. Reported Net Loss for the year was (611 M) with profit before taxes, overhead, and interest of 5.76 B.
Bausch Health has a frail financial position based on the latest SEC disclosures
Over 80.0% of the company shares are held by institutions such as insurance companies
Latest headline from thelincolnianonline.com: Nomura Holdings Inc. Has 148.67 Million Stock Position in Bausch Health Companies Inc.

Bausch Health Companies Upcoming and Recent Events

Earnings reports are used by Bausch Health to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Bausch Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Bausch Largest EPS Surprises

Earnings surprises can significantly impact Bausch Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1997-02-27
1996-12-310.060.070.0116 
2001-04-26
2001-03-310.180.20.0211 
1996-07-17
1996-06-300.040.060.0250 
View All Earnings Estimates

Bausch Health SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Bausch Health prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Bausch Health investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Bausch Health Companies specific information freely available to individual and institutional investors to make a timely investment decision.
22nd of February 2024
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
13th of February 2024
Unclassified Corporate Event
View
7th of February 2024
Unclassified Corporate Event
View
1st of February 2024
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
13th of November 2023
Financial Statements and Exhibits
View
2nd of November 2023
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
29th of September 2023
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Completion of Acquisition or Disposition of Assets. Entry into a Material Definitive Agreement
View
18th of September 2023
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View

Bausch Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Bausch Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bausch Health Companies backward and forwards among themselves. Bausch Health's institutional investor refers to the entity that pools money to purchase Bausch Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Ing Groep Nv2023-12-31
7.5 M
Mizuho Markets Americas Llc2023-12-31
M
Citadel Advisors Llc2023-09-30
6.1 M
Mfn Partners Management, Lp2023-12-31
M
Kohlberg Kravis Roberts & Co Lp2023-12-31
5.2 M
Norges Bank2023-12-31
3.9 M
Royal Bank Of Canada2023-09-30
3.6 M
Natixis Sa2023-12-31
3.2 M
Bnp Paribas Arbitrage, Sa2023-09-30
M
Icahn Carl C2023-12-31
34.7 M
Goldentree Asset Management Lp2023-12-31
27.6 M
Note, although Bausch Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bausch Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 3.29 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bausch Health's market, we take the total number of its shares issued and multiply it by Bausch Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Bausch Profitablity

Bausch Health's profitability indicators refer to fundamental financial ratios that showcase Bausch Health's ability to generate income relative to its revenue or operating costs. If, let's say, Bausch Health is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Bausch Health's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Bausch Health's profitability requires more research than a typical breakdown of Bausch Health's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (0.07) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.21 %, which entails that for every 100 dollars of revenue, it generated $0.21 of operating income.
Last ReportedProjected for 2024
Return on Average Assets(0.02)(0.02)
Return on Average Equity 0.65  0.70 
Return on Invested Capital 0.04  0.04 
Return on Sales 0.11  0.12 

Management Efficiency

Bausch Health Companies has Return on Asset of 0.0382 % which means that on every $100 spent on assets, it made $0.0382 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (6.8652) %, meaning that it generated no profit with money invested by stockholders. Bausch Health's management efficiency ratios could be used to measure how well Bausch Health manages its routine affairs as well as how well it operates its assets and liabilities. At present, Bausch Health's Return on Invested Capital is projected to increase slightly based on the last few years of reporting. The current year's Return on Sales is expected to grow to 0.12, whereas Return on Average Assets are forecasted to decline to (0.02). At present, Bausch Health's Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Assets Non Current is expected to grow to about 23.3 B, whereas Tax Assets are forecasted to decline to about 1.8 B.
Last ReportedProjected for 2024
Book Value per Share(2.80)(2.87)
Enterprise Value over EBIT 26.00  26.42 
Enterprise Value over EBITDA 11.07  15.37 
Price to Book Value(2.87)(3.09)
Tangible Assets Book Value per Share 26.61  27.42 
Enterprise Value24.6 B29.1 B
Tangible Asset Value9.7 B9.8 B
The analysis of Bausch Health's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Bausch Health's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Bausch Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
0.789

Technical Drivers

As of the 28th of February, Bausch Health shows the Mean Deviation of 1.63, downside deviation of 2.08, and Risk Adjusted Performance of 0.1386. Bausch Health Companies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyze and collected data for nineteen technical drivers for Bausch Health Companies, which can be compared to its rivals. Please confirm Bausch Health Companies jensen alpha, potential upside, skewness, as well as the relationship between the maximum drawdown and semi variance to decide if Bausch Health Companies is priced correctly, providing market reflects its regular price of 9.18 per share. Given that Bausch Health has jensen alpha of 0.1246, we suggest you to validate Bausch Health Companies's prevailing market performance to make sure the company can sustain itself at a future point.

Bausch Health Companies Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bausch Health middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bausch Health Companies. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
.

Bausch Health Companies Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bausch Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bausch Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bausch Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Bausch Health Predictive Daily Indicators

Bausch Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bausch Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Bausch Health Forecast Models

Bausch Health's time-series forecasting models are one of many Bausch Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bausch Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Bausch Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bausch Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bausch shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bausch Health. By using and applying Bausch Stock analysis, traders can create a robust methodology for identifying Bausch entry and exit points for their positions.
Last ReportedProjected for 2024
EBITDA Margin 0.25  0.25 
Gross Margin 0.71  0.79 
Profit Margin(0.07)(0.07)

Current Bausch Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bausch analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bausch analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
9.67Buy8Odds
Bausch Health Companies current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Bausch analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bausch stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bausch Health Companies, talking to its executives and customers, or listening to Bausch conference calls.
Bausch Analyst Advice Details

Bausch Stock Analysis Indicators

Bausch Health Companies stock analysis indicators help investors evaluate how Bausch Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bausch Health shares will generate the highest return on investment. By understating and applying Bausch Health stock analysis, traders can identify Bausch Health position entry and exit signals to maximize returns.
Begin Period Cash Flow591 M
Total Stockholder Equity-1 B
Property Plant And Equipment Net1.7 B
Cash And Short Term Investments947 M
Cash947 M
50 Day M A8.0784
Net Interest Income-1.3 B
Total Current Liabilities4.3 B
Forward Price Earnings2.4528
Investments-2.1 B
Interest Expense1.3 B
Stock Based Compensation132 M
Long Term Debt21.9 B
Common Stock Shares Outstanding364.9 M
Tax Provision221 M
Quarterly Earnings Growth Y O Y1.115
Other Current Assets1.1 B
Accounts Payable719 M
Net Debt21.4 B
Other Operating Expenses3.6 B
Non Current Assets Total21.8 B
Liabilities And Stockholders Equity27.4 B
Non Currrent Assets Other307 M
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Note that the Bausch Health Companies information on this page should be used as a complementary analysis to other Bausch Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Bausch Stock analysis

When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is Bausch Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.115
Earnings Share
(1.62)
Revenue Per Share
23.998
Quarterly Revenue Growth
0.098
Return On Assets
0.0382
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.